{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:27:17Z","timestamp":1768544837321,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.contraception.2014.08.006","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T08:35:17Z","timestamp":1407832517000},"page":"565-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception"],"prefix":"10.1016","volume":"90","author":[{"given":"YongMei","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-4739","authenticated-orcid":false,"given":"Vivian","family":"Brache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Cochon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7085-4525","authenticated-orcid":false,"given":"Alistair","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Jos\u00e9","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horacio","family":"Croxatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena","family":"Plagianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Merkatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Blithe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine","family":"Sitruk-Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"29","key":"10.1016\/j.contraception.2014.08.006_bb0005","first-page":"1","article-title":"Use of contraception in the United States: 1982\u20132008","volume":"23","author":"Mosher","year":"2010","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.contraception.2014.08.006_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1933719112459239","article-title":"Ulipristal blocks ovulation by inhibiting progesterone receptor-dependent pathways intrinsic to the ovary","volume":"4","author":"Nallasamy","year":"2013","journal-title":"Reprod Sci"},{"key":"10.1016\/j.contraception.2014.08.006_bb0015","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0039-128X(03)00130-2","article-title":"Pharmacologic properties of CDB(VA)-2914","volume":"10\u201313","author":"Gainer","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2014.08.006_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2003.12.004","article-title":"In vitro antiprogestational\/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone","volume":"3","author":"Attardi","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2014.08.006_bb0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"9714","author":"Glasier","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2014.08.006_bb0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"5","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2014.08.006_bb0035","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2006-2816","article-title":"VA2914 Study Group. Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic- pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial","volume":"9","author":"Chabbert-Buffet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2014.08.006_bb0040","article-title":"A study to evaluate the effect of a contraceptive vaginal ring delivering a daily dose of 400\u2013500 \u03bcg of CDB-2914 on pharmacokinetics and pharmacodynamics in normal cycling women","volume":"312","author":"Croxatto","year":"2003"},{"key":"10.1016\/j.contraception.2014.08.006_bb0045","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2011.10.003","article-title":"Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women","volume":"5","author":"Brache","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.08.006_bb0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"5","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.contraception.2014.08.006_bb0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.contraception.2012.08.038","article-title":"Vaginal ring delivery of selective progesterone receptor modulators for contraception","volume":"3","author":"Jensen","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.08.006_bb0060","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/humrep\/15.5.1100","article-title":"Circulating concentrations of the antiprogestin CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration","volume":"5","author":"Larner","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2014.08.006_bb0065","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/humrep\/17.6.1472","article-title":"Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women","volume":"6","author":"Johansson","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2014.08.006_bb0070","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/humrep\/deg255","article-title":"Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium","volume":"6","author":"Brenner","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2014.08.006_bb0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"6","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.contraception.2014.08.006_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/humrep\/deg022","article-title":"Effect of long-term treatment with low-dose mifepristone on the endometrium","volume":"18","author":"Baird","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2014.08.006_bb0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mce.2012.02.021","article-title":"The immninent dawn of SPRMs in obstetrics and gynecology","volume":"2","author":"Chabbert-Buffet","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2014.08.006_bb0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/13625187.2013.813930","article-title":"Effects of ulipristal acetate on sperm DNA fragmentation during in vitro incubation","volume":"5","author":"Munuce","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2014.08.006_bb0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/13625187.2012.725877","article-title":"Effect of exposure to ulipristal acetate on sperm function","volume":"6","author":"Munuce","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2014.08.006_bb0100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.contraception.2012.08.021","article-title":"Emergency contraception \u2013 mechanisms of action","volume":"3","author":"Gemzell-Danielsson","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.08.006_bb0105","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.fertnstert.2008.12.057","article-title":"Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914","volume":"6","author":"Stratton","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2014.08.006_bb0110","first-page":"99","article-title":"Progesterone receptor modulator associated endometrial changes: a pilot dose escalation study of ulipristal acetate. Facts, Views and Vision in ObGyn","author":"Williams","year":"2010","journal-title":"Sci J Flemish Soc Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.08.006_bb0115","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/humrep\/des221","article-title":"Ulipristal acetate does not impact human normal breast tissue","volume":"9","author":"Communal","year":"2012","journal-title":"Hum Reprod"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241400609X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241400609X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T21:24:09Z","timestamp":1538342649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078241400609X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S001078241400609X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.08.006","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}